High altitude cerebral edema (HACE) is a life-threatening illness that develops during the rapid ascent to high altitudes, but its underlying mechanisms remain unclear. Growing evidence has implicated inflammation in the susceptibility to and development of brain edema. In the present study, we investigated the inflammatory response and its roles in HACE in mice following high altitude hypoxic injury. We report that acute hypobaric hypoxia induced a slight inflammatory response or brain edema within 24 h in mice. However, the lipopolysaccharide (LPS)-induced systemic inflammatory response rapidly aggravated brain edema upon acute hypobaric hypoxia exposure by disrupting blood-brain barrier integrity and activating microglia, increasing water permeability via the accumulation of aquaporin-4 (AQP4), and eventually leading to impaired cognitive and motor function. These findings demonstrate that hypoxia augments LPS-induced inflammation and induces the occurrence and development of cerebral edema in mice at high altitude. Here, we provide new information on the impact of systemic inflammation on the susceptibility to and outcomes of HACE.
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Introduction
High altitudes and mountains cover one-fifth of the earth's surface. With advances in technology, millions of people travel to high altitude areas for recreational, religious, economic and military purposes (Gallagher and Hackett, 2004) . High altitude is characterized by hypobaric hypoxia, decreased temperatures, lower humidity and increased ultraviolet radiation (Gallagher and Hackett, 2004; Netzer et al., 2013) . Among these factors, hypobaric hypoxia is regarded as the main factor contributing to altitude-related illness, which is quite common in those who are not adequately acclimated (MacInnis et al., 2010; Rodway et al., 2003; Bailey et al., 2009 ). Altitude-related illnesses include acute mountain sickness (AMS), high altitude pulmonary edema (HAPE) and high altitude cerebral edema (HACE). Among these, HACE is the most serious and can be lethal (Gallagher and Hackett, 2004; Eide and Asplund, 2012) . HACE often occurs in those who abruptly ascend to over 3000 m, but the lowest reported altitude known to induce HACE was 2100 m (Dickinson, 1979) . The prevalence of HACE is estimated to be 0.5 to 1% among persons at altitudes of 4,000-5,000 m (Bärtsch and Swenson, 2013) . HACE is regarded as the end-stage of AMS and is characterized by truncal ataxia and decreased consciousness. If the appropriate treatment is not received within a certain period of time, coma may evolve, followed by death within 24 h due to brain herniation (Hackett and Roach, 2001) . However, the mechanisms that cause HACE symptoms remain elusive, and methods for the prevention and treatment of HACE are limited (Guo et al., 2014) .
Inflammation plays important roles in many diseases. High altitude exposure is often associated with gastrointestinal disorders, inflammation and increased risk of infection (Kleessen et al., http://dx.doi.org/10.1016/j.bbi.2017.04.013 0889-1591/Ó 2017 Elsevier Inc. All rights reserved.
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